Macular Thickness and Visual Acuity in Diabetic Hypertensive Patients
- Conditions
- Macular Edema
- Registration Number
- NCT05209971
- Lead Sponsor
- Sohag University
- Brief Summary
In this study, measurements of central macular thickness using optical coherence tomography along with examination of visual acuity by Snellen's chart in diabetic hypertensive patients will be done .
- Detailed Description
correlate relationship between optical coherence tomography changes and visual acuity in patients with type 2 diabetes and hypertension
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Type 2 diabetic patients with hypertension .
Exclusion Criteria
- Patients with type 1 diabetes mellitus .
- Ocular disease ( such as high myopia , glaucoma ) .
- Patients with opacities in the media ( corneal opacities , dense cataract , vitreous hemorrhage ) .
- Systemic medication (Tamoxifen , Chloroquine , Canthaxanthine ) to avoid its effect on macular thickness .
- Central visual field defect that prevents fixation on OCT .
- Intraocular inflammation such as anterior or posterior uveitis .
- Refractive error greater than 6 diopter .
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method macular thickness in diabetic hypertensive patients June 2022 measurement of central macular thickness by optical coherence tomography
- Secondary Outcome Measures
Name Time Method